Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

Subnormal plasma levels of high-density lipoprotein cholesterol (HDL-C) constitute a major cardiovascular risk factor; raising low HDL-C levels may therefore reduce the residual cardiovascular risk that frequently presents in dyslipidaemic subjects despite statin therapy. Cholesteryl ester transfer...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, M. John, Le Goff, Wilfried, Guerin, Maryse, Kontush, Anatol
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806550/
https://www.ncbi.nlm.nih.gov/pubmed/19825813
http://dx.doi.org/10.1093/eurheartj/ehp399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806550/
https://www.ncbi.nlm.nih.gov/pubmed/19825813
http://dx.doi.org/10.1093/eurheartj/ehp399

Ejemplares similares